Charleroi, Belgium

Iteos Therapeutics


USPTO Granted Patents = 7

% Expired Patents = 42.9


Trademarks = 2

Forward Citations = 4

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Stefano Crosignani (7 out of 23 patents)

silverMedal Sandra Cauwenberghs (5 out of 6 patents)

bronzeMedal Gregory Driessens (5 out of 9 patents)

4.  Frederik Deroose (4 out of 5 patents)

5.  Sacha Ninkovic (2 out of 24 patents)

6.  Stephanie Anne Scales (2 out of 8 patents)

7.  Martin James Wythes (2 out of 41 patents)

8.  Indrawan James McAlpine (2 out of 14 patents)

9.  Michael Raymond Collins (2 out of 21 patents)

10.  Andreas Maderna (2 out of 23 patents)

11.  Manfred Kraus (1 out of 2 patents)

12.  Indrawan James Mcalpine (0 patent)


7 patents:

Company Overview
Iteos Therapeutics is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immuno-oncology therapeutics. The company's approach focuses on the modulation of the tumor microenvironment to enhance the effectiveness of immunotherapy treatments. With a diverse pipeline of innovative drug candidates, Iteos Therapeutics is committed to improving outcomes for cancer patients.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Iteos Therapeutics USPTO Patent Assignee Logo
7 Patents

#4 in Charleroi

#338 in Belgium

Charleroi, BE
Charleroi, Belgium
Forward Citations = 4

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Iteos Therapeutics. Retrieved from https://idiyas.com/company/iteos-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…